Kinnate Biopharma Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2020 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Kinnate Biopharma Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2023.
- Kinnate Biopharma Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$27.7M, a 31.5% decline year-over-year.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$100M, a 12.4% decline from 2022.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$89M, a 25.3% decline from 2021.
- Kinnate Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$71.1M, a 135% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)